产品编号 :
Cas No. :
CAS No. |
150779-71-8 |
|---|---|
中文名称 |
2-羟基-5-(2-(2,5-二甲氧基苯基)乙基)苯甲酸甲酯 |
英文名称 |
Methyl 5-(2,5-dimethoxyphenethyl)-2-hydroxybenzoate |
别名 |
SDZ 281 977;SDZ-LAP 977;Benzoic acid, 5-[2-(2,5-dimethoxyphenyl)ethyl]-2-hydroxy-, methyl ester;SDZ281 977,SDZ-281-977,SDZ281977;Methyl 5-[2-(2,5-dimethoxyphenyl)ethyl]-2-hydroxybenzoate |
标准英文名 |
methyl 5-(2,5-dimethoxyphenethyl)-2-hydroxybenzoate |
分子式 |
C18H20O5 |
分子量 |
316.35 |
精确分子量 |
316.13 |
SMILES |
COC1=C(C=C(OC)C=C1)CCC2=CC(C(OC)=O)=C(O)C=C2 |
标准SMILES |
COC1C=CC(=CC=1CCC1=CC(=C(O)C=C1)C(=O)OC)OC |
用途 |
SDZ281-977 is an EGF receptor tyrosine kinase inhibitor and a derivative of Lavendustin A; it exhibits antitumor activity against human tumor cell lines including A431 (vulvar carcinoma), MIAPaCa-2 (pancreatic tumor), and MDA-MB-231 (breast carcinoma) in vitro, with IC50 values of 0.21 μM, 0.29 μM, and 0.43 μM, respectively; in vivo, it demonstrates dose-dependent inhibition of A431 tumor growth in nude mice following intravenous administration (1–10 mg/kg for 4 weeks) or oral administration (30 mg/kg, resulting in 54% tumor growth inhibition after 3 weeks). |
InChIKey |
GZOFTOHENYHNMS-UHFFFAOYSA-N |
|
|
评论 |
|---|